Latest Breaking News On - Markj gilbert - Page 1 : comparemela.com

JW Therapeutics: Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

SHANGHAI, May 30, 2024 /PRNewswire/ JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology

China
Hong-kong
Shanghai
Markj-gilbert
A-bristol-myers-squibb
Ltd-the-company
Prnewswire-jw-cayman-therapeutics-co
China-national-medical-products-administration
National-significant-new-drug-development-program
Rheumatology-congress
Clearing-limited-hkex
European-alliance-of-associations

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
Shanghai
Hong-kong
Markj-gilbert
A-bristol-myers-squibb
China-national-medical-products-administration
Ltd-the-company
Jw-cayman-therapeutics-co
European-alliance-of-associations
National-significant-new-drug-development-program
Rheumatology-congress
Clearing-limited-hkex

JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva(R) in Patients with Relapsed or Refractory Mantle Cell Lymphoma

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China

China
Markj-gilbert
Chinj-hematol
China-national-medical-products-administration
Bristol-myers-squibb
National-medical-products-administration
National-significant-new-drug-development-program
Biological-license-application
Mantle-cell-lymphoma
Breakthrough-therapy-designation
Priority-review
Chief-medical-officer

2seventy bio (TSVT) and JW Therapeutics To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

2seventy bio (TSVT) and JW Therapeutics To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Steve-bernstein
Markj-gilbert
Nasdaq
Chief-medical-officer

2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies

Initial MAGE-A4 T-cell collaboration program set to enter clinic ahead of schedule by end of 2023 Companies plan to add programs in oncology and autoimmune disease to collaboration .

Hong-kong
China
Markj-gilbert
Steve-bernstein
Nasdaq
Linkedin
Exchange-commission
Clearing-limited
Chief-medical-officer
Note-regarding-forward-looking-statements
Private-securities-litigation-reform-act
Quarterly-report